China Dealbook: Meridian leads $17m round in Aipinji; Frontier Biotech gets $43m funding

China Dealbook: Meridian leads $17m round in Aipinji; Frontier Biotech gets $43m funding

A clerk counts Chinese yuan and U.S. dollar banknotes at a branch of Bank of China in Taiyuan

Aipinji has raised $17 million in a funding round led by Meridian Capital China and Hangzhou Hongfan Tiansheng Capital. In a separate deal, Frontier Biotechnologies Inc., a drug development bio-pharmaceutical company, has raised $43 million from Huaxin Century Investment Group and others.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter